Pharmaceutical company settles civil allegations for $2.8M
Published: March 29,2012
MADISON — A Mississippi-based pharmaceutical company has agreed to pay $2.8 million to resolve civil allegations that the manufacturer falsely marketed skin products to receive government funding.
U.S. Attorney John M. Bales said yesterday Cypress Pharmaceutical Inc., a subsidiary and CEO Max Draughn will pay $1.6 million to the military’s TRICARE program and $1.2 million to state Medicaid programs.
The government alleges that Cypress subsidiary Hawthorne Pharmaceuticals Inc. claimed that three skin products carried the Food and Drug Administration’s “safe and effective” designation when the treatments didn’t. The government also claims the regulatory status of the products was misrepresented.
Bales says a whistleblower who sued under the False Claims Act received $300,000 as part of the settlement.
An official for Madison-based Cypress didn’t immediately return a phone call seeking comment.
To sign up for Mississippi Business Daily Updates, click here.
FOLLOW THE MBJ ON TWITTERMy Tweets
Top Posts & Pages
- Outside group files arguments supporting McDaniel
- Court rules board can discipline West Virginia radiologist
- DAVID DALLAS: Mississippi's in'adequate' public schools
- MDEQ fines metalworking firm over hazardous waste
- Payday lender, fired executive exchanging blame for lender’s regulatory woes
- C Spire now offering new Blast Motion technology for athletes
- Grain buyer’s bankruptcy could take steep toll on Delta farmers
- Mississippi no longer has highest unemployment rate in nation
- Mad Genius, Eyevox owner acquires Mississippi Film Studios